For Paris SSII, the exoskeleton is a convincing substrate by which neuroscience will control the symptomatic temperament of multiple sclerosis. Read more >
Paris
DISTRIBUTOR, EUROPE, FRANCE, IDF, Paris Cap
CAPGEMINI
Place de l’Etoile, 11 Rue de Tilsitt 75017 Paris FRANCE